{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT04459208: Not Applicable Interventional Completed Aortic Valve Stenosis
(2020)
Source URL:
Class:
MIXTURE
Status:
Investigational
Source:
NCT00511810: Phase 2/Phase 3 Interventional Completed Major Depressive Disorder
(2007)
Source URL:
Class:
MIXTURE
Status:
Investigational
Class:
MIXTURE
Status:
Investigational
Source:
NCT02204709: Not Applicable Interventional Terminated Obesity
(2015)
Source URL:
Class:
MIXTURE
Status:
Investigational
Source:
JAN:CRATAEGUS FRUIT [JAN]
Source URL:
Class:
MIXTURE
Status:
Investigational
Source:
NCT02089165: Phase 2 Interventional Completed Healthy
(2014)
Source URL:
Class:
MIXTURE
Status:
Investigational
Source:
NCT01224249: Phase 1 Interventional Completed Selenium Status
(2010)
Source URL:
Class:
MIXTURE
Class:
MIXTURE
Allylprodine (Ro 2-7113) is an opioid analgesic. It is stereoselective, with one isomer being much more active. Allylprodine is included in Schedule I of the US Controlled Substances Act 1970 as a Narcotic with ACSCN 9602 and a 2014 annual aggregate manufacturing quota of 2 grammes.
Status:
Investigational
Source:
USAN:CINODINE HYDROCHLORIDE [USAN]
Source URL:
Class:
MIXTURE
Status:
Investigational
Source:
INN:vecantoxatug [INN]
Source URL:
Class:
PROTEIN
